Vessel bioengineering - Development of small-diameter arterial grafts -

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 12-19

  Tara, Shuhei ^a   Rocco, Kevin A ^b   Hibino, Narutoshi ^a   Sugiura, Tadahisa ^a   Kurobe, Hirotsugu ^a   Breuer, Christopher K ^a   Shinoka, Toshiharu ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell seeding; Coronary artery disease; Scaffolds; Small diameter arterial grafts; Tissue engineered vascular grafts

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; POLITEF; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; POLYURETHAN; TISSUE SCAFFOLD;

ARTERIAL PRESSURE; ARTERY GRAFT; BIOENGINEERING; BLOOD VESSEL GRAFT; CORONARY ARTERY DISEASE; EXTRACELLULAR MATRIX; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SMALL DIAMETER ARTERY GRAFT; TISSUE ENGINEERED VASCULAR GRAFT; ANIMAL; BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; CONGENITAL HEART MALFORMATION; METHODOLOGY; PATHOPHYSIOLOGY; TISSUE ENGINEERING;

ABSORBABLE IMPLANTS; ANIMALS; BLOOD VESSEL PROSTHESIS; HEART DEFECTS, CONGENITAL; HUMANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84891124484     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1440     Document Type: Review

References (61)

1. The VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation 1992; 86: 121-130.
2. Bourassa MG. Long-term vein graft patency. Curr Opin Cardiol 1994; 9: 685-691.
3. Lamm P, Juchem G, Milz S, Schuffenhauer M, Reichart B. Autologous endothelialized vein allograft: A solution in the search for smallcaliber grafts in coronary artery bypass graft operations. Circulation 2001; 104: I108-I114.
4. Conte MS. The ideal small arterial substitute: A search for the Holy Grail? FASEB J 1998; 12: 43-45.
5. Ravi S, Chaikof EL. Biomaterials for vascular tissue engineering. Regen Med 2010; 5: 107-120.
6. Vacanti JP, Langer R. Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999; 354: SI32-SI34.
7. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-926.
8. Naito Y, Shinoka T, Duncan D, Hibino N, Solomon D, Cleary M, et al. Vascular tissue engineering: Towards the next generation vascular grafts. Adv Drug Deliv Rev 2011; 63: 312-323.
9. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.
10. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001; 344: 532-533.
11. Rustad KC, Sorkin M, Levi B, Longaker MT, Gurtner GC. Strategies for organ level tissue engineering. Organogenesis 2010; 6: 151-157.
12. Riha GM, Lin PH, Lumsden AB, Yao Q, Chen C. Application of stem cells for vascular tissue engineering [Review]. Tissue Eng 2005; 11: 1535-1552.
13. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
14. Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, et al. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 2008; 29: 1454-1463.
15. Enomoto S, Sumi M, Kajimoto K, Nakazawa Y, Takahashi R, Takabayashi C, et al. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material. J Vasc Surg 2010; 51: 155-164.
16. Zhou M, Qiao W, Liu Z, Shang T, Qiao T, Mao C, et al. Development and in vivo evaluation of small diameter vascular grafts engineered by outgrowth endothelial cells and electrospun chitosan/poly(epsiloncaprolactone) nanofibrous scaffolds. Tissue Eng Part A 2013 November 7, doi:10.1089/ten.tea.2013.0020.
17. Wu H, Fan J, Chu CC, Wu J. Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci Mater Med 2010; 21: 3207-3215.
18. Pektok E, Nottelet B, Tille JC, Gurny R, Kalangos A, Moeller M, et al. Degradation and healing characteristics of small-diameter poly (epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008; 118: 2563-2570.
19. Wang S, Mo XM, Jiang BJ, Gao CJ, Wang HS, Zhuang YG, et al. Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency. Int J Nanomed 2013; 8: 2131-2139.
20. Su Y, Su Q, Liu W, Jin G, Mo X, Ramakrishna S. Dual-drug encapsulation and release from core-shell nanofibers. J Biomater Sci Polym Ed 2011 March 18, doi:10.1163/092050611X564137.
21. Matsuda T, Miwa H. A hybrid vascular model biomimicking the hierarchic structure of arterial wall: Neointimal stability and neoarterial regeneration process under arterial circulation. J Thorac Cardiovasc Surg 1995; 110: 988-997.
22. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003; 24: 759-767.
23. Swartz DD, Russell JA, Andreadis ST. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 2005; 288: H1451-H1460.
24. Tschoeke B, Flanagan TC, Koch S, Harwoko MS, Deichmann T, Ella V, et al. Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng Part A 2009; 15: 1909-1918.
25. Koch S, Flanagan TC, Sachweh JS, Tanios F, Schnoering H, Deichmann T, et al. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 2010; 31: 4731-4739.
26. Dahl SL, Blum JL, Niklason LE. Bioengineered vascular grafts: Can we make them off-the-shelf? Trends Cardiovasc Med 2011; 21: 83-89.
27. Schmidt CE, Baier JM. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000; 21: 2215-2231.
28. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials 2007; 28: 3587-3593.
29. Sandusky GE Jr, Badylak SF, Morff RJ, Johnson WD, Lantz G. Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am J Pathol 1992; 140: 317-324.
30. Sandusky GE, Lantz GC, Badylak SF. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J Surg Res 1995; 58: 415-420.
31. Hiles MC, Badylak SF, Lantz GC, Kokini K, Geddes LA, Morff RJ. Mechanical properties of xenogeneic small-intestinal submucosa when used as an aortic graft in the dog. J Biomed Mater Res 1995; 29: 883-891.
32. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-1040.
33. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003; 23: 1002-1006.
34. Quint C, Kondo Y, Manson RJ, Lawson JH, Dardik A, Niklason LE. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci USA 2011; 108: 9214-9219.
35. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-365.
36. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: A multicentre cohort study. Lancet 2009; 373: 1440-1446.
37. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002; 90: e40-e48.
38. Hibino N, Duncan DR, Nalbandian A, Yi T, Qyang Y, Shinoka T, et al. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg 2012; 143: 696-703.
39. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
40. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978; 84: 498-504.
41. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001; 71: S327-S331.
42. Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev 2009; 89: 957-989.
43. Yue X, van der Lei B, Schakenraad JM, van Oene GH, Kuit JH, Feijen J, et al. Smooth muscle cell seeding in biodegradable grafts in rats: A new method to enhance the process of arterial wall regeneration. Surgery 1988; 103: 206-212.
44. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, et al. Functional arteries grown in vitro. Science 1999; 284: 489-493.
45. Peck M, Gebhart D, Dusserre N, McAllister TN, L'Heureux N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 2012; 195: 144-158.
46. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol 2012; 5: 19.
47. Hashi CK, Zhu Y, Yang GY, Young WL, Hsiao BS, Wang K, et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc Natl Acad Sci USA 2007; 104: 11915-11920.
48. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
49. Asahara T, Kawamoto A, Masuda H. Circulating endothelial progenitor cells for vascular medicine [Concise Review]. Stem Cells 2011; 29: 1650-1655.
50. Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA 2010; 107: 4669-4674.
51. Noishiki Y, Tomizawa Y, Yamane Y, Matsumoto A. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 1996; 2: 90-93.
52. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: Clinical experience. Biomaterials 2003; 24: 2303-2308.
53. Hibino N, Yi T, Duncan DR, Rathore A, Dean E, Naito Y, et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 2011; 25: 4253-4263.
54. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, et al. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 2010; 139: 431-436.
55. Mirensky TL, Nelson GN, Brennan MP, Roh JD, Hibino N, Yi T, et al. Tissue-engineered arterial grafts: Long-term results after implantation in a small animal model. J Pediatr Surg 2009; 44: 1127-1132.
56. Cho SW, Kim IK, Kang JM, Song KW, Kim HS, Park CH, et al. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. Tissue Eng Part A 2009; 15: 901-912.
57. Shen G, Tsung HC, Wu CF, Liu XY, Wang XY, Liu W, et al. Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells. Cell Res 2003; 13: 335-341.
58. Gearhart J. New potential for human embryonic stem cells. Science 1998; 282: 1061-1062.
59. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
60. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2: 3081-3089.
61. Hibino N, Nalbandian A, Devine L, Martinez RS, McGillicuddy E, Yi T, et al. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: Novel filter system versus traditional density centrifugation method. Tissue Eng Part C Methods 2011; 17: 993-998.